Texas Biomedical Research Institute:製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C9358)
◆英語タイトル:Texas Biomedical Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9358
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年11月
◆ページ数:32
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Texas Biomedical Research Institute (Texas Biomed) is a medical research institute that develops treatment for chronic and infectious diseases. The institute conducts biomedical research and discovers new technologies for preventing and eradicating infectious diseases. Its research program includes study on cardiovascular disease, diabetes, obesity, cancer, psychiatric disorders, liver disease, malaria, muscular dystrophy, fever viruses, AIDS, hepatitis, parasitic infections and neurodegenerative diseases. The institute also conducts research on genetics, virology and immunology. Texas Biomed is headquartered in San Antonio, Texas, the US.

Texas Biomedical Research Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Texas Biomedical Research Institute Enters into Research Contract with Mapp Biopharma 10
Mymetics Enters into Agreement with Texas Biomedical Research Institute 11
Southwest Research Institute Enters into Agreement with Texas Biomedical Research Institute 12
Texas Biomedical Research Institute – Key Competitors 13
Texas Biomedical Research Institute – Key Employees 14
Texas Biomedical Research Institute – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Government and Public Interest 16
Jul 24, 2018: Research shows a promising new class of antibodies protects against HIV-1 infection 16
Jul 17, 2018: Tackling liver cancer using CRISPR to develop a new animal model — TXBioBytes Podcast Episode 013 17
Jun 22, 2018: Repurposing Promising Cancer Drugs May Lead to a New Approach to Treating TB 18
Dec 11, 2017: New Animal Model for Zika Developed at Texas Biomed Useful for Testing Vaccines and Treatments 19
Nov 22, 2017: Texas Biomedical Forum Announces 2017 Grant Recipients 20
Nov 15, 2017: Search for Novel Biomarkers Indicating Early Cardiovascular Disease Risk Wins Funding To Design Larger Scale Study in People of Mexican Ancestry 22
Nov 07, 2017: Promising new drug for Hep B tested at Texas Biomedical Research Institute 24
Oct 10, 2017: Researcher receives NIH grant to study biomarkers of variation in brain regions important to neuropsychiatric disorders 25
Sep 20, 2017: Texas Biomed Scientists part of $11.5 million NIH project aimed at combating drug resistance in the malaria parasite 26
Aug 21, 2017: Texas Biomed part of team receiving five-year, $4.4 million NIH grant for novel TB vaccine testing 27
Jan 25, 2017: Texas Biomed scientist receives 5-year, $4.6 million MERIT Award for malaria research 29
Product News 31
Aug 16, 2018: New Hepatitis B vaccine testing at Texas Biomed 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Key Facts 2
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Texas Biomedical Research Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Texas Biomedical Research Institute Enters into Research Contract with Mapp Biopharma 10
Mymetics Enters into Agreement with Texas Biomedical Research Institute 11
Southwest Research Institute Enters into Agreement with Texas Biomedical Research Institute 12
Texas Biomedical Research Institute, Key Competitors 13
Texas Biomedical Research Institute, Key Employees 14

List of Figures
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Texas Biomedical Research Institute:製薬・医療:M&Aディール及び事業提携情報(Texas Biomedical Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆